FDC Ltd.

₹411.05

FDC Ltd.

₹411.05

₹411.05

14.4 (3.63%) - 8 Apr 2025 04:27 PM

About Company

FDC Limited make modest beginning in 1936, with marketing of vitamins and a range of prescription formulations. The company is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialised formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Over its long history, the company has maintained a distinguished reputation for high-quality, affordable products and built a market-leading brand portfolio. The company also set-up globally approved, multi-location manufacturing facilities for Active Pharmaceuticals Ingredients (APIs) as well as Finished Dosage Forms. These facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh. FDC markets hundreds of products in India and exports many of these to various countries.

Market Cap. ₹6,458 Cr.
52 Week - High/Low ₹659/366
P/E Ratio 23.58
P/B Ratio 3.08
Enterprise Value ₹7,034 Cr.
ROE % 15.06
RSI Value 44.56
EMA 50 421.46
EMA 200 462.05
Net Profit 307 Cr.
Net Profit 3year growth 4.3 Cr.
Net Profit 3 year (back) 294 Cr.
Debt to Equity 0.0 %
EPS Growth TTM -6.3 %
Current Ratio 2.21 %
100 Day SMA 460 Rs.
200 Day SMA 491 Rs.
21 Day SMA 401 Rs.
50 Day SMA 421 Rs.
Book Value 129 Rs.
EV/EBITDA Ratio 17
QoQ EPS Growth -51 %
QoQ Operating Profit Growth -37 %
QoQ Sales Growth -9 %
Sales Latest Quarter 459 Cr.
YoY Sales Growth 1 %
Market Cap. ₹6,458 Cr.
52 Week - High/Low ₹659/366
P/E Ratio 23.53
P/B Ratio 3.08
Enterprise Value ₹7,036 Cr.
ROE % 14.96
RSI Value 44.56
EMA 50 421.46
EMA 200 462.05
Net Profit 305 Cr.
Net Profit 3year growth -3.49 Cr.
Net Profit 3 year (back) 301 Cr.
Debt to Equity 0.0 %
EPS Growth TTM -3.93 %
Current Ratio 2.22 %
100 Day SMA 460 Rs.
200 Day SMA 491 Rs.
21 Day SMA 401 Rs.
50 Day SMA 421 Rs.
Book Value 129 Rs.
EV/EBITDA Ratio 17
QoQ EPS Growth -49 %
QoQ Operating Profit Growth -34 %
QoQ Sales Growth -10 %
Sales Latest Quarter 464 Cr.
YoY Sales Growth 1 %

Growth

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.